Update on heparin: what do we need to know?

By Weitz Daniel   Weitz Jeffrey  

Journal of Thrombosis and Thrombolysis, Vol. 29, Iss. 2, 2010-02 ,pp. : 199-207

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Mllerian hormone-based approach to controlled ovarian stimulation for assisted conception

By Nelson Scott M.   Yates Robin W.   Lyall Helen   Jamieson Maybeth   Traynor Isabel   Gaudoin Marco   Mitchell Paul   Ambrose Pat   Fleming Richard  

Human Reproduction, Vol. 24, Iss. 4, 2009-04 ,pp. : 867-875

Oxford University Press

Access to resources Recommend Favorite

Anti-Mllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

By Carlsen S.M.   Vanky E.   Fleming R.  

Human Reproduction, Vol. 24, Iss. 7, 2009-07 ,pp. : 1732-1738

Oxford University Press

Access to resources Recommend Favorite

Anti-Mllerian hormone and anti-Mllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women

By Kevenaar Marlies E.   Themmen Axel P.N.   Laven Joop S.E.   Sonntag Barbara   Fong Sharon Lie   Uitterlinden Andr G.   de Jong Frank H.   Pols Huibert A.P.   Simoni Manuela   Visser Jenny A.  

Human Reproduction, Vol. 22, Iss. 6, 2007-06 ,pp. : 1547-1554

Oxford University Press

Access to resources Recommend Favorite

In the Wake of the AFFIRM Trial: What We Still Don't Know About the Management of Atrial Fibrillation and Where We Need to Go

By Wyse D.G.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 2, 2003-01 ,pp. : 130-135

Springer Publishing Company

Access to resources Recommend Favorite